Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damageuses different caspase cascades and is independent of Fas/Fas ligand interaction
Jh. Lai et al., Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damageuses different caspase cascades and is independent of Fas/Fas ligand interaction, J IMMUNOL, 166(11), 2001, pp. 6914-6924
Spontaneous or therapeutic induction of T cell apoptosis plays a critical r
ole in establishing transplantation tolerance and maintaining remission of
autoimmune diseases. We investigated the mechanisms of apoptosis induced by
Chinese and Western anti-rheumatic drugs (ARDs) in human T cells. We found
that hydroxychloroquine, Tripterygium wilfordii hook F, and tetrandrine Je
t), but not methotrexate, at therapeutic concentrations can cause T cell de
ath. In addition, Tet selectively killed T cells, especially activated T ce
lls. Although ARD-induced cytotoxicity was mediated through apoptotic mecha
nisms, Fas/Fas ligand interaction was not required. We further demonstrated
that the processes of phosphatidylserine externalization and DNA damage al
ong the ARD-induced T cell apoptotic pathway could operate independently, a
nd that selective inhibition of DNA damage by caspase inhibitors did not pr
event T cells from undergoing cell death. Moreover, we found that Tet- and
Tripterygium wilfordii hook F-induced T cell DNA damage required caspase-3
activity, and hydroxychloroquine-induced T cell DNA damage was mediated thr
ough a caspase-3- and caspase-8-independent, but Z-Asp-Glu-Val-Asp-fluometh
yl ketone-sensitive, signaling pathway. Finally, the observation that ARD-i
nduced activation of caspase-3 in both Fas-sensitive and Fas-resistant Jurk
at T cells indicates that Fas/Fas ligand interaction plays no role in ARD-i
nduced T cell apoptosis. Our observations provide new information about the
complex apoptotic mechanisms of ARDs, and have implications for combining
Western and Chinese ARDs that have different immunomodulatory mechanisms in
the therapy of autoimmune diseases and transplantation rejection.